San Francisco, 25 August 2025: The Report Veterinary Digital Pathology Market Size, Share & Trends Analysis Report By Animal Type (Livestock, Companion, Exotic), By Product (Whole Slide Imaging Systems, Image Analysis Software), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
The global veterinary digital pathology market size is expected to reach USD 1,050.2 million by 2030, registering a CAGR of 14.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors, including the rising demand for faster and more accurate diagnostics, growing caseloads in veterinary hospitals, and the increasing adoption of telepathology. For example, large veterinary hospitals are adopting digital pathology to handle high volumes of biopsy samples efficiently, enabling pathologists to diagnose remotely and provide quicker treatment decisions. Additionally, advancements in AI-powered image analysis tools are improving diagnostic precision, while the growing use of digital records and the need for remote consultations, especially highlighted during the COVID-19 pandemic have further accelerated the shift toward digital solutions in veterinary care.
The latest innovation in digital pathological solutions is one of the key factors contributing to market growth. For instance, according to an article published by Andrew Pritchett and Veterinary Practice, in January 2023, digital pathology holds significant potential to revolutionize veterinary pathology, especially in response to challenges posed by the COVID-19 pandemic and ongoing staffing shortages. A prime example is the Pannoramic 1000RX, currently the highest-capacity whole-slide scanner on the market, capable of processing up to 1,000 slides simultaneously. Renowned for its efficiency, the scanner uses advanced technology to focus solely on the tissue of interest, eliminating blank areas. This approach maintains high image resolution and quality while minimizing file size-an advantage when sharing diagnostic results with pathologists and clients.
Furthermore, chronic diseases are increasingly prevalent among dogs in the United States, reflecting broader trends in pet health. For instance, according to an article published by International Journal of Veterinary Sciences and Animal Husbandry, in 2024, the incidence of chronic kidney disease in dogs was 2.64%. CKD often progresses silently, making histopathological evaluation of kidney biopsies crucial for early-stage detection and effective treatment planning. Digital pathology enables high-resolution scanning and analysis of renal tissue, allowing veterinary pathologists to detect subtle changes that may be missed under conventional microscopy.
Moreover, high initial investment costs significantly hamper the veterinary digital pathology market by limiting adoption, particularly among small and mid-sized clinics. For example, a standard digital pathology system comprising a slide scanner, image server, and specialized software typically costs between USD 110,000 to USD 130,000 in the Asia Pacific region. Smaller veterinary practices, which often operate on tight budgets, may find these upfront costs prohibitive, opting instead to continue using traditional glass slide methods. This financial barrier restricts market growth and slows the widespread integration of digital pathology, especially in less urbanized or resource-constrained regions.
Request sample report of Veterinary Digital Pathology Market@ https://www.grandviewresearch.com/industry-analysis/veterinary-digital-pathology-market-report/request/rs1
The market is driven by several key factors, including the increasing prevalence of chronic diseases in animals, growing pet adoption, and the rising demand for rapid and accurate diagnostic tools. Technological advancements such as whole-slide imaging and AI-based diagnostic algorithms are enhancing diagnostic efficiency and accuracy, further fueling market growth. Additionally, the growing awareness about animal health, the expansion of veterinary telemedicine, and the need for remote consultation and collaboration among pathologists are encouraging the adoption of digital pathology solutions.
The rising prevalence of chronic diseases in animals, such as cancer, diabetes, and kidney disorders, is significantly driving the market growth. These long-term conditions require ongoing monitoring and detailed diagnostic evaluations, which digital pathology enables through high-resolution image analysis, remote consultations, and streamlined data sharing. For instance, according to an article published by the National Library of Medicine, in January 2025, lymphoma remained one of the most prevalent cancers in dogs in 2024, accounting for approximately 24% of all canine malignancies and 85% of hematological cancers. The most common form, multicentric lymphoma, represents about 84% of cases and typically manifests as painless lymph node enlargement. A dog diagnosed with lymphoma may need repeated histopathological assessments to monitor the progression or response to therapy tasks made faster and more accurate through digital pathology platforms. This demand for efficient, precise, and scalable diagnostic tools is pushing veterinary practices to adopt digital solutions, fueling market expansion.
Furthermore, the rising adoption of pet insurance is significantly driving the market by increasing pet owners' ability to afford advanced diagnostic services. As insurance coverage reduces out-of-pocket expenses for veterinary care, more owners are opting for comprehensive diagnostic procedures, including digital pathology, which offers rapid and accurate analysis of tissue samples. This trend enhances early disease detection and treatment planning, encouraging clinics to invest in digital pathology systems. For example, a pet insurance policy that covers diagnostic tests enables a veterinarian to utilize digital pathology to detect cancerous cells in a dog’s biopsy, ensuring timely and precise intervention that might otherwise be cost-prohibitive without insurance.
